Health
One in Eight US Adults Have Taken Ozempic or Similar Drugs
- Over half of people who tried shots say they’re hard to afford
- Health insurance didn’t make drugs more affordable in survey
An Eli Lilly & Co. Zepbound injection pen.
Photographer: Shelby Knowles/BloombergThis article is for subscribers only.
One in eight US adults has tried medications from the fast-growing class of new diabetes and obesity drugs that includes Ozempic and Zepbound, underscoring how quickly the treatments have gained popularity.
Of those who’ve tried the drugs, about half are currently still taking them, according to a poll from health research organization KFF released Friday. If the KFF survey’s results reflect the total US adult population, it would mean that roughly 30 million Americans have tried the medications.